Solana price prediction leads weekly stablecoin inflows and DEX revenue while SOL trades near oversold support, eyeing a rebound toward the $130 resistance zoneSolana price prediction leads weekly stablecoin inflows and DEX revenue while SOL trades near oversold support, eyeing a rebound toward the $130 resistance zone

Solana price prediction bulls eye rebound as $1.3b stablecoin inflows hit key support

2 min read

Solana price prediction leads weekly stablecoin inflows and DEX revenue while SOL trades near oversold support, eyeing a rebound toward the $130 resistance zone.

Summary
  • Solana price prediction captured about $1.3b in weekly net stablecoin inflows, far ahead of rival chains.
  • SOL trades near technical support with oversold signals but still bearish momentum.
  • Ethereum saw sizable stablecoin outflows as Solana led DEX revenue and volume among major networks.

Solana (SOL) price prediction as bulls recorded the largest weekly stablecoin inflows among major blockchain networks, according to data from Artemis, as the cryptocurrency’s price traded near technical support levels.

The blockchain registered approximately $1.3 billion in net stablecoin inflows over the seven-day period, representing the highest positive net change among competing networks, according to the data. Solana was the only chain to record such substantial inflows during the period measured.

SOL, the network’s native token, traded near support levels following a daily decline and a larger weekly drop. The asset’s 24-hour trading volume increased significantly during the period, according to market data.

Institutional investment in Solana-based exchange-traded funds remained limited. U.S. spot SOL ETFs reported minimal inflows last week, marking the lowest levels in recent records, according to fund flow data.

Ethereum, by contrast, registered substantial stablecoin outflows during the same period, topping outflow rankings among major blockchain networks, the Artemis data showed. Other networks including Ripple, Polygon PoS, Aptos, and Arbitrum recorded mixed results but remained significantly behind Solana in stablecoin activity.

Solana also led in decentralized exchange revenue and volume during the period, according to blockchain analytics data. The network’s performance in short-term DEX revenue outpaced other layer one and layer two blockchain platforms.

The broader cryptocurrency market declined recently amid regulatory concerns and liquidations of leveraged positions, according to market analysts. Major digital assets remained below recent price highs.

Technical indicators showed SOL trading near oversold territory with signs of potential recovery, though momentum measures remained bearish, according to chart analysis. The cryptocurrency traded within a defined range between support and resistance levels.

Analysts noted that a sustained move above resistance levels would be required to signal a renewed upward trend, while failure to hold support could trigger further downside movement. The asset targets a rebound toward the $130 resistance level, according to technical projections.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11